The biological sample collection kits market size has grown rapidly in recent years. It will grow from $11.39 billion in 2025 to $12.78 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to surge in infectious disease testing programs, expansion of hospital and diagnostic center testing capacity, early adoption of standardized swab and vtm kits, growth in clinical research and sample-based studies, increasing awareness of safe specimen handling protocols,.
The biological sample collection kits market size is expected to see rapid growth in the next few years. It will grow to $19.26 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rising demand for homecare and self-collection test kits, growing use of dna and rna collection kits in genomics applications, higher utilization of blood and saliva kits in chronic disease and screening programs, expansion of research biobanking and longitudinal cohort studies, increasing preference for user-friendly and transport-stable collection formats. Major trends in the forecast period include increasing use of biological sample collection kits in diagnostic testing, growing adoption of at-home and remote sample collection solutions, rising utilization of swabs, vtm, and blood collection kits in clinical settings, expansion of sample collection for research and biobanking applications, focus on sterility, safety, and sample integrity during transportation and storage.
The increasing prevalence of infectious diseases is expected to drive the growth of the biological sample collection kits market. Infectious diseases, caused by pathogens such as bacteria, viruses, fungi, or parasites, are transmissible between individuals. The rise in these diseases can be attributed to factors like greater global travel, urbanization, antimicrobial resistance, environmental changes, and inadequate healthcare infrastructure. Biological sample collection kits play a critical role in managing infectious diseases by allowing safe and efficient specimen collection for diagnostic, monitoring, and research purposes. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based national public health agency, reported a 16% increase in tuberculosis cases in the U.S. from 2022 to 2023, totaling 9,615 cases. The incidence rate rose from 2.5 to 2.9 per 100,000 people. Of these, 76% of cases occurred in non-U.S.-born individuals, marking an 18% increase, while U.S.-born cases rose by 9%. Significant increases were observed among Hispanic (23%) and Black (28%) groups among non-U.S.-born individuals, highlighting demographic shifts in TB incidence. As a result, the growing number of infectious diseases is fueling the expansion of the biological sample collection kits market.
Major companies operating in the biological sample collection kits market are focusing on developing innovative products, such as personalized diagnostic test kits, to better meet customer needs with enhanced capabilities. Personalized diagnostic test kits are designed to identify specific biomarkers or genetic information tailored to an individual’s unique health profile, enabling more customized medical diagnosis. For instance, in March 2023, Cue Health, a US-based diagnostic testing service provider, introduced at-home diagnostic test kits. These kits contain all required materials for safe, simple, and private sample collection. After the sample is sent to and analyzed by an independent, CLIA-certified laboratory, easy-to-understand results are securely delivered to users through the Cue Health App, along with relevant information regarding their health condition or concern.
In March 2024, Halma plc, a UK-based group specializing in life-saving technology companies, acquired Rovers Medical Devices B.V., a Netherlands-based manufacturer of sample-collection devices, for €85 million (approximately US$92.6 million). With this acquisition, Halma aimed to strengthen its women’s health and diagnostics portfolio by incorporating Rovers’ established cervical-cancer sample-collection technologies, including cervical cell sampling brushes. Rovers Medical Devices is a Netherlands-based company focused on developing sample-collection solutions used in the prevention and diagnosis of cervical cancer.
Major companies operating in the biological sample collection kits market are Thermo Fisher Scientific Inc, Roche Holding AG, Abbott Laboratories, Becton Dickinson and Company, 3M Company, Copan Diagnostics Inc, Puritan Medical Products Inc, HiMedia Laboratories Pvt Ltd, Omega Laboratories Ltd, VIRCELL SL, Titan Biotech Ltd, BTNX Inc, MWE Medical Wire and Equipment Co Ltd, Quidel Corporation, Greiner Bio‑One International GmbH, Terumo Corporation, Sarstedt AG & Co KG, QIAGEN NV, Deltalab Spain, Trinity Biotech Ltd.
North America was the largest region in the biological sample collection kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological sample collection kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biological sample collection kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biological sample collection kits market by increasing the cost of plastic consumables, sterile containers, swab fibers, transport vials, and preservative chemicals sourced through global supply chains, leading to higher manufacturing and procurement expenses. The impact is particularly evident across swabs, viral transport media, and blood collection kit categories manufactured in Asia-Pacific and European production hubs that depend on imported materials and components. Hospitals and clinics, diagnostic centers, and homecare testing programs are experiencing price pressures and slower purchasing cycles as tariff-related costs are passed through to end users. However, tariffs are also encouraging localized molding, reagent production, and regional assembly initiatives, which may strengthen domestic manufacturing resilience and supply security in the long term.
The biological sample collection kits market research report is one of a series of new reports that provides biological sample collection kits market statistics, including biological sample collection kits industry global market size, regional shares, competitors with a biological sample collection kits market share, detailed biological sample collection kits market segments, market trends and opportunities, and any further data you may need to thrive in the biological sample collection kits industry. This biological sample collection kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biological sample collection kits are essential tools crafted for the safe and efficient gathering, preservation, and transportation of biological specimens such as blood, saliva, urine, or tissue. These kits typically comprise sterile containers, swabs, and preservatives, ensuring the samples' integrity for diagnostic or research purposes.
The primary types of biological sample collection kits include swabs, viral transport media, blood collection kits, and others. Swabs serve as instruments for gathering samples from different body sites for medical testing, commonly featuring a soft tip affixed to a stick. These kits find applications in diagnostics and research and are utilized by various end users such as hospitals, clinics, home testing facilities, diagnostics centers, and more.
The biological sample collection kits market consists of sales of blood collection tubes, saliva collection devices, urine collection containers, swabs for microbial sampling, and tissue biopsy kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The biological sample collection kits market size is expected to see rapid growth in the next few years. It will grow to $19.26 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rising demand for homecare and self-collection test kits, growing use of dna and rna collection kits in genomics applications, higher utilization of blood and saliva kits in chronic disease and screening programs, expansion of research biobanking and longitudinal cohort studies, increasing preference for user-friendly and transport-stable collection formats. Major trends in the forecast period include increasing use of biological sample collection kits in diagnostic testing, growing adoption of at-home and remote sample collection solutions, rising utilization of swabs, vtm, and blood collection kits in clinical settings, expansion of sample collection for research and biobanking applications, focus on sterility, safety, and sample integrity during transportation and storage.
The increasing prevalence of infectious diseases is expected to drive the growth of the biological sample collection kits market. Infectious diseases, caused by pathogens such as bacteria, viruses, fungi, or parasites, are transmissible between individuals. The rise in these diseases can be attributed to factors like greater global travel, urbanization, antimicrobial resistance, environmental changes, and inadequate healthcare infrastructure. Biological sample collection kits play a critical role in managing infectious diseases by allowing safe and efficient specimen collection for diagnostic, monitoring, and research purposes. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based national public health agency, reported a 16% increase in tuberculosis cases in the U.S. from 2022 to 2023, totaling 9,615 cases. The incidence rate rose from 2.5 to 2.9 per 100,000 people. Of these, 76% of cases occurred in non-U.S.-born individuals, marking an 18% increase, while U.S.-born cases rose by 9%. Significant increases were observed among Hispanic (23%) and Black (28%) groups among non-U.S.-born individuals, highlighting demographic shifts in TB incidence. As a result, the growing number of infectious diseases is fueling the expansion of the biological sample collection kits market.
Major companies operating in the biological sample collection kits market are focusing on developing innovative products, such as personalized diagnostic test kits, to better meet customer needs with enhanced capabilities. Personalized diagnostic test kits are designed to identify specific biomarkers or genetic information tailored to an individual’s unique health profile, enabling more customized medical diagnosis. For instance, in March 2023, Cue Health, a US-based diagnostic testing service provider, introduced at-home diagnostic test kits. These kits contain all required materials for safe, simple, and private sample collection. After the sample is sent to and analyzed by an independent, CLIA-certified laboratory, easy-to-understand results are securely delivered to users through the Cue Health App, along with relevant information regarding their health condition or concern.
In March 2024, Halma plc, a UK-based group specializing in life-saving technology companies, acquired Rovers Medical Devices B.V., a Netherlands-based manufacturer of sample-collection devices, for €85 million (approximately US$92.6 million). With this acquisition, Halma aimed to strengthen its women’s health and diagnostics portfolio by incorporating Rovers’ established cervical-cancer sample-collection technologies, including cervical cell sampling brushes. Rovers Medical Devices is a Netherlands-based company focused on developing sample-collection solutions used in the prevention and diagnosis of cervical cancer.
Major companies operating in the biological sample collection kits market are Thermo Fisher Scientific Inc, Roche Holding AG, Abbott Laboratories, Becton Dickinson and Company, 3M Company, Copan Diagnostics Inc, Puritan Medical Products Inc, HiMedia Laboratories Pvt Ltd, Omega Laboratories Ltd, VIRCELL SL, Titan Biotech Ltd, BTNX Inc, MWE Medical Wire and Equipment Co Ltd, Quidel Corporation, Greiner Bio‑One International GmbH, Terumo Corporation, Sarstedt AG & Co KG, QIAGEN NV, Deltalab Spain, Trinity Biotech Ltd.
North America was the largest region in the biological sample collection kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological sample collection kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biological sample collection kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biological sample collection kits market by increasing the cost of plastic consumables, sterile containers, swab fibers, transport vials, and preservative chemicals sourced through global supply chains, leading to higher manufacturing and procurement expenses. The impact is particularly evident across swabs, viral transport media, and blood collection kit categories manufactured in Asia-Pacific and European production hubs that depend on imported materials and components. Hospitals and clinics, diagnostic centers, and homecare testing programs are experiencing price pressures and slower purchasing cycles as tariff-related costs are passed through to end users. However, tariffs are also encouraging localized molding, reagent production, and regional assembly initiatives, which may strengthen domestic manufacturing resilience and supply security in the long term.
The biological sample collection kits market research report is one of a series of new reports that provides biological sample collection kits market statistics, including biological sample collection kits industry global market size, regional shares, competitors with a biological sample collection kits market share, detailed biological sample collection kits market segments, market trends and opportunities, and any further data you may need to thrive in the biological sample collection kits industry. This biological sample collection kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biological sample collection kits are essential tools crafted for the safe and efficient gathering, preservation, and transportation of biological specimens such as blood, saliva, urine, or tissue. These kits typically comprise sterile containers, swabs, and preservatives, ensuring the samples' integrity for diagnostic or research purposes.
The primary types of biological sample collection kits include swabs, viral transport media, blood collection kits, and others. Swabs serve as instruments for gathering samples from different body sites for medical testing, commonly featuring a soft tip affixed to a stick. These kits find applications in diagnostics and research and are utilized by various end users such as hospitals, clinics, home testing facilities, diagnostics centers, and more.
The biological sample collection kits market consists of sales of blood collection tubes, saliva collection devices, urine collection containers, swabs for microbial sampling, and tissue biopsy kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Biological Sample Collection Kits Market Characteristics
3. Biological Sample Collection Kits Market Supply Chain Analysis
4. Global Biological Sample Collection Kits Market Trends and Strategies
5. Biological Sample Collection Kits Market Analysis of End Use Industries
7. Global Biological Sample Collection Kits Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Biological Sample Collection Kits Total Addressable Market (TAM) Analysis for the Market
9. Biological Sample Collection Kits Market Segmentation
10. Biological Sample Collection Kits Market Regional and Country Analysis
11. Asia-Pacific Biological Sample Collection Kits Market
12. China Biological Sample Collection Kits Market
13. India Biological Sample Collection Kits Market
14. Japan Biological Sample Collection Kits Market
15. Australia Biological Sample Collection Kits Market
16. Indonesia Biological Sample Collection Kits Market
17. South Korea Biological Sample Collection Kits Market
18. Taiwan Biological Sample Collection Kits Market
19. South East Asia Biological Sample Collection Kits Market
20. Western Europe Biological Sample Collection Kits Market
21. UK Biological Sample Collection Kits Market
22. Germany Biological Sample Collection Kits Market
23. France Biological Sample Collection Kits Market
24. Italy Biological Sample Collection Kits Market
25. Spain Biological Sample Collection Kits Market
26. Eastern Europe Biological Sample Collection Kits Market
27. Russia Biological Sample Collection Kits Market
28. North America Biological Sample Collection Kits Market
29. USA Biological Sample Collection Kits Market
30. Canada Biological Sample Collection Kits Market
31. South America Biological Sample Collection Kits Market
32. Brazil Biological Sample Collection Kits Market
33. Middle East Biological Sample Collection Kits Market
34. Africa Biological Sample Collection Kits Market
36. Biological Sample Collection Kits Market Competitive Landscape and Company Profiles
37. Biological Sample Collection Kits Market Other Major and Innovative Companies
40. Biological Sample Collection Kits Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Biological Sample Collection Kits Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses biological sample collection kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biological sample collection kits? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biological sample collection kits market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Swabs; Viral Transport Media; Blood Collection Kits2) By Application: Diagnostics; Research
3) By End-Use: Hospitals And Clinics; Homecare; Diagnostics Centers; Other End-Uses
Subsegments:
1) By Swabs: Nasopharyngeal Swabs; Oropharyngeal Swabs; Flocked Swabs; Polyester Swabs2) By Viral Transport Media (VTM): Liquid VTM; Dry VTM
3) By Blood Collection Kits: Venous Blood Collection Kits; Capillary Blood Collection Kits; Fingerstick Blood Collection Kits
Companies Mentioned: Thermo Fisher Scientific Inc; Roche Holding AG; Abbott Laboratories; Becton Dickinson and Company; 3M Company; Copan Diagnostics Inc; Puritan Medical Products Inc; HiMedia Laboratories Pvt Ltd; Omega Laboratories Ltd; VIRCELL SL; Titan Biotech Ltd; BTNX Inc; MWE Medical Wire and Equipment Co Ltd; Quidel Corporation; Greiner Bio‑One International GmbH; Terumo Corporation; Sarstedt AG & Co KG; QIAGEN NV; Deltalab Spain; Trinity Biotech Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Biological Sample Collection Kits market report include:- Thermo Fisher Scientific Inc
- Roche Holding AG
- Abbott Laboratories
- Becton Dickinson and Company
- 3M Company
- Copan Diagnostics Inc
- Puritan Medical Products Inc
- HiMedia Laboratories Pvt Ltd
- Omega Laboratories Ltd
- VIRCELL SL
- Titan Biotech Ltd
- BTNX Inc
- MWE Medical Wire and Equipment Co Ltd
- Quidel Corporation
- Greiner Bio‑One International GmbH
- Terumo Corporation
- Sarstedt AG & Co KG
- QIAGEN NV
- Deltalab Spain
- Trinity Biotech Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.78 Billion |
| Forecasted Market Value ( USD | $ 19.26 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
